A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience

Correlation between the Lymphocyte-To-Monocyte Ratio (LMR) and Child–Pugh and MELD/MELDNa Scores in Vietnamese Patients with Liver Cirrhosis

“…Meanwhile, these proportions in Charif's study were Child A (19.2%), Child B (54.6%), and Child C (26.1%) [30] and, in Fayad's study, were Child A (12.2%), Child B (35.8%), and Child C (52%) [24]. This shows a marked difference in the distribution across Child classifications, especially for Child B and C. The mean values of MELD and MELDNa scores and LMR in our study were similar to the findings by other authors [19,25,36].…”

“…Thus, the male predominance is apparent, especially in developing countries. The mean age of our study population was 60 years (ranging from 22 to 88 years), being higher than previous literature, i.e., 55.0 ± 11.1 by Vo et al [20], 54.8 ± 8 by Hassan et al [25], and 53.1 ± 12.0 by Jamil et al [11]. Thus, our patients were a bit older.…”

Child–Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis

“…The characteristics of the 119 papers were shown in Table 1 . The countries included Austria (n = 1), 11 Belgium (n = 2), 38 , 96 China (n = 26), 20 , 21 , 27 , 30 , 31 , 53 – 55 , 59 , 60 , 74 , 84 , 102 , 109 , 112 , 113 , 117 , 119 – 121 , 123 – 128 Cuba (n = 1), 47 Czech Republic (n = 1), 44 Egypt (n = 1), 51 France (n = 6), 25 , 37 , 41 , 71 , 77 , 114 Germany (n = 7), 12 , 48 – 50 , 92 , 105 , 111 Greece (n = 1), 82 Hungary (n = 1), 61 India (n = 10), 19 , 29 , 39 , 40 , 67 , 75 , 76 , 86 , 98 , 115 Iran (n = 1), 87 Italy (n = 5), 22 , 24 , 43 , 46 , 91 Ivory Coast (n = 1), 13 Japan (n = 2), 57 , 106 Mexico (n = 1), 45 Nepal (n = 1), 28 Pakistan (n = 2), 62 , 97 Poland (n = 1), ...…”

“… 13 , 16 , 18 , 20 – 22 , 24 , 25 , 28 , 29 , 33 , 39 , 43 , 46 , 47 , 49 , 51 , 53 – 55 , 59 , 60 , 64 , 66 , 68 , 74 , 76 , 77 , 82 , 83 , 90 , 95 , 97 , 98 , 100 , 103 , 106 , 118 , 121 , 124 , 126 , 127 In 42 studies, no patient with HCC was included; 11 , 15 , 18 , 20 – 22 , 24 – 26 , 29 , 31 , 33 , 45 – 47 , 49 , 50 , 53 – 56 , 59 , 61 , 64 , 66 , 69 , 74 , 82 , 84 , 86 , 95 , 97 , 98 , 101 – 103 , ...…”

“…As for the meta-analysis, 77 papers were excluded, 12 , 14 – 16 , 20 – 23 , 26 – 31 , 33 – 39 , 41 , 43 – 47 , 49 – 51 , 53 – 55 , 57 – 60 , 63 , 64 , 66 , 68 – 73 , 75 , 78 , 79 , 81 – 83 , 85 , 86 , 88 – 90 , 92 , 93 , 95 , 96 , 99 – 101 , 103 , 105 , 106 , 113 , 114 , 118 , 120 – 124 , 126 , 128 because 76 studies were lacking of relevant data 12 , 14 – 16 , 20 – 23 , 26 – 31 , 33 – 39 , 41 , 43 – 47 , 49 – 51 , 53 – 55 , 57 – 59 , 63 , 64 , 66 ,…”